Clinical Trial Update: Multiple Biomarkers in Undiagnosed Pleural Effusion

View source ↗

Summary

A clinical trial evaluating multiple biomarkers for undiagnosed pleural effusion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Pleural Effusion

Snippet

Sponsor: Fujirebio Diagnostics, Inc. | Conditions: Pleural Effusion, Pleural Effusion, Malignant | Status: TERMINATED